Elderly patients undergoing major vascular surgery: Risk factors and medication associated with risk reduction

Archives of Gerontology and Geriatrics

Volumn 48, Issue 1, 2009, Pages 116-120

  Feringa, Harm H H ^a   Bax, Jeroen J ^b   Karagiannis, Stefanos E ^a   Noordzij, Peter ^a   van Domburg, Ron ^a   Klein, Jan ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac medication; Cardiovascular outcome; Elderly; Non cardiac surgery; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STATIN;

AGED; ARTICLE; CARDIOVASCULAR RISK; FEMALE; GERIATRIC SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; VASCULAR SURGERY; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CARDIOVASCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; NETHERLANDS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 56949099883     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2007.11.003     Document Type: Article

References (24)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. Br. Med. J. 324 (2002) 71-86
2. Concato J., Shah N., and Horwitz R.I. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N. Engl. J. Med. 342 (2000) 1887-1892
3. Cruickshank J.M. Beta-blockers continue to surprise us. Eur. Heart J. 21 (2000) 354-364
4. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., and Caramelli B. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J. Vasc. Surg. 39 (2004) 967-976
5. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., Fleisher L.A., Froehlich J.B., Gusberg R.J., Leppo J.A., Ryan T., Schlant R.C., Winters Jr. W.L., Gibbons R.J., Antman E.M., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Jacobs A.K., Hiratzka L.F., Russell R.O., and Smith Jr. S.C. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery. Executive summary report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105 (2002) 1257-1267
6. Goldman L., Caldera D.L., Nussbaum S.R., Southwick F.S., Krogstad D., Murray B., Burke D.S., O'Malley T.A., Goroll A.H., Caplan C.H., Nolan J., Carabello B., and Slater E.E. Multifactorial index of cardiac risk in non-cardiac surgical procedures. N. Engl. J. Med. 297 (1977) 845-850
7. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of β-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N. Engl. J. Med. 339 (1998) 489-497
8. Hirsch A.T., and Duprez D. The potential role of angiotensin-converting enzyme inhibition in peripheral arterial disease. Vasc. Med. 8 (2003) 273-278
9. Kertai M.D., Boersma E., Westerhout C.M., van Domburg R., Klein J., Bax J.J., van Urk H., and Poldermans D. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am. J. Med. 116 (2004) 96-103
10. Lee T.H., Marcantonio E.R., Mangione C.M., Thomas E.J., Polanczyk C.A., Cook E.F., Sugarbaker D.J., Donaldson M.C., Poss R., Ho K.K., Ludwig L.E., Pedan A., and Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999) 1043-1049
11. Lonn E.M., Yusuf S., Jha P., Montague T.J., Teo K.K., Benedict C.R., and Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 90 (1994) 2056-2069
12. Lopez-Sendon J., Swedberg K., McMurray J., Tamargo J., Maggioni A.P., Dargie H., Tendera M., Waagstein F., Kjekshus J., Lechat P., and Torp-Pedersen C. Task force on β-blockers of the European Society of Cardiology. Expert consensus document on β-adrenergic receptor blockers. Eur. Heart J. 25 (2004) 1341-1362
13. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 72 (1990) 153-184
14. Mangano D.T., Browner W.S., Hollenberg M., London M.J., Tubau J.F., and Tateo I.M. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing non-cardiac surgery. The Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 323 (1990) 1781-1788
15. Miettinen T.A., Pyorala K., Olsson A.G., Musliner T.A., Cook T.J., Faergeman O., Berg K., Pedersen T., and Kjekshus J. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96 (1997) 4211-4218
16. Moreno P.R., and Fuster V. The year in atherothrombosis. J. Am. Coll. Cardiol. 44 (2004) 2099-2110
17. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., Baars H.F., Yo T.I., Trocino G., Vigna C., Roelandt J.R., and van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N. Engl. J. Med. 341 (1999) 1789-1794
18. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., Thomson I.R., Lansberg P.J., Fleisher L.A., Klein J., van Urk H., Roelandt J.R., and Boersma E. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
19. Santinga J.T., Rosman H.S., Rubenfire M., Maciejko J.J., Kobylak L., McGovern M.E., and Behounek B.D. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am. J. Med. 96 (1994) 509-515
20. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., Ford I., Gaw A., Hyland M., Jukema J.W., Kamper A.M., Macfarlane P.W., Meinders A.E., Norrie J., Packard C.J., Perry I.J., Stott D.J., Sweeney B.J., Twomey C., and Westendorp R.G. Prospective study of pravastatin in the elderly at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
21. Tiret L., Desmonts J.M., Hatton F., and Vourc'h G. Complications associated with anaesthesia-a prospective survey in France. Can. Anaesth. Soc. J. 33 (1986) 336-344
22. Viskin S., Kitzis I., Lev E., Zak Z., Heller K., Villa Y., Zajarias A., Laniado S., and Belhassen B. Treatment with β-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J. Am. Coll. Cardiol. 25 (1995) 1327-1332
23. Wijeysundera D.N., and Beattie W.S. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth. Analg. 97 (2003) 634-641
24. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342 (2000) 145-153